Mumbai, May 12, 2025 — India’s nutraceutical industry took center stage at the NutrifyToday C-Suite SumFlex 2025, a purpose-driven business summit held in Mumbai that is being hailed as a turning point in the country's quest to become a global powerhouse in responsible nutrition.
The summit, which brought together leadership from pharmaceuticals, nutrition science, venture capital, and public policy, aimed to scale India’s nutraceutical market to USD 100 billion by 2047, up from its current $18 billion valuation (2023), growing at a robust 13.5% CAGR, according to Invest India.
“SumFlex was not just an event — it was a declaration of intent,” said Amit Srivastava, Founder of Nutrify Today.
“It is time India moves from being the world's nutraceutical factory to becoming its innovation and integrity capital.”
A Strategic Leap: From Backend to Global Epicentre
The event underscored India's transformation into a science-backed, innovation-led player in the $3 trillion global wellness economy. Industry experts likened the moment to the United States’ early 2000s nutraceutical breakout — a phase when strategic clarity, regulation, and innovation aligned.
The summit welcomed delegates from the United States, South Korea, Malaysia, and other countries, spotlighting India's increasing global influence in wellness innovation.
“We are watching India emerge as the epicentre of responsible, science-driven nutrition for the world,” said Dr. Anand Swaroop, President, Cepham USA.
Policy Moves: Rural India as the Growth Engine
A landmark development came in the form of a Memorandum of Understanding between India Chambers and the Rural Economic Forum, facilitated by Dr. Nitin Pangotra, Advisor to the MSME Ministry. The agreement will enable micro-enterprises and rural innovators to tap directly into global supply chains, from raw ingredients to value-added finished products.
This is a direct output of Project One Future, India’s initiative to merge rural and industrial ecosystems to achieve inclusive economic scaling.
Industry Titans and Strategic Tools
SumFlex 2025 featured a formidable lineup of C-suite leaders and investors:
- Shivam Puri, MD & CEO, Cipla Health
- Ganesh Nayak, Executive Director, Zydus Group
- Shantaprasad Nagarmath, CEO, Dr. Reddy’s & Nestlé Health Science
- Sanjaya Mariwala, Executive Chairman, Omniactive Health
- Dipanjan Basu, Co-founder, Fireside Ventures
- William Hood, MD, William Hood & Company
- Tim Opler, MD, Stifel
Their discussions centered on:
- Cross-border M&A strategies
- Licensing of novel actives
- AI-driven commercialization models
The summit unveiled Dealsphere.NutrifyToday.com, a proprietary platform that cuts product commercialization time to just 15 days, a game-changer for go-to-market speed in science-backed formulations.
Launchpad for Science-Backed Innovation
SumFlex 2025 doubled as a platform for major product and technology debuts:
- Celevida Diafiber, a metabolic health product by Dr. Reddy’s and Nestlé Health Science
- Rx.NutrifyToday.com, the world’s first digital reference platform for doctors to verify nutraceutical health claims, safety data, and ingredient mechanisms
The platform, currently public, will launch a doctor-exclusive version in October 2025.
Redefining the Business Summit Format
Eschewing typical footfall-driven models, SumFlex 2025 focused on outcome-driven networking. Each session and engagement was tightly curated to deliver strategic RoI.
“C-Suite SumFlex 2025 has redefined how business summits are measured. This was about value, not vanity metrics,” noted one institutional investor.
India’s Moment on the Global Wellness Stage
As momentum builds, the message is clear: India isn’t following trends — it’s setting them.
“We’re shaping a new global model of responsible nutrition,” said Srivastava.
“This is India’s moment. And we’re owning it with purpose.”
Our Opinion on the News
SumFlex 2025 was not a mere industry meetup — it was a strategic inflection point. By aligning rural India, digital innovation, global capital, and high-credibility science, the summit has created a credible path to $100 billion.
India now holds the tools, talent, and timing to lead the global wellness economy. But execution will hinge on three things:
- Maintaining regulatory integrity
- Sustaining science-first product standards
- And scaling fast without diluting trust
If it succeeds, India will not just be a supplier of wellness — it will be the standard-bearer.